Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | 5-hydroxytryptamine receptor 3A | ||
Ligand | BDBM50259913 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEBML_1691999 | ||
IC50 | 13000±n/a nM | ||
Citation | Hill, MD; Fang, H; Digavalli, SV; Healy, FL; Gallagher, L; Post-Munson, D; Chen, P; Natale, J; Benitex, Y; Morgan, D; Lodge, N; Bristow, L; Macor, JE; Olson, RE Development of spiroguanidine-derived?7 neuronal nicotinic receptor partial agonists. Bioorg Med Chem Lett27:578-581 (2017) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
5-hydroxytryptamine receptor 3A | |||
Name: | 5-hydroxytryptamine receptor 3A | ||
Synonyms: | 5-HT-3 | 5-HT3 | 5-HT3A | 5-HT3R | 5-hydroxytryptamine receptor 3 (5-HT3) | 5-hydroxytryptamine receptor 3A (5-HT3a) | 5-hydroxytryptamine receptor 3A (5HT3A) | 5HT3A_HUMAN | 5HT3R | HTR3 | HTR3A | Serotonin 3 (5-HT3) receptor | Serotonin 3 receptor (5HT3) | Serotonin receptor 3A | Serotonin-gated ion channel receptor | Serotonin-gated ion channel receptor 3 | ||
Type: | Protein | ||
Mol. Mass.: | 55283.27 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P46098 | ||
Residue: | 478 | ||
Sequence: |
| ||
BDBM50259913 | |||
n/a | |||
Name | BDBM50259913 | ||
Synonyms: | CHEMBL4082605 | ||
Type | Small organic molecule | ||
Emp. Form. | C16H19ClN6S | ||
Mol. Mass. | 362.88 | ||
SMILES | CN1C(Nc2nc3ccc(Cl)nc3s2)=NCC11CN2CCC1CC2 |c:15,THB:1:16:19.20:22.23,(45.22,-30.28,;46.25,-31.42,;47.77,-31.26,;48.55,-29.93,;50.08,-29.93,;50.99,-31.17,;52.45,-30.69,;53.78,-31.46,;55.12,-30.69,;55.12,-29.14,;56.45,-28.37,;53.78,-28.38,;52.45,-29.15,;50.99,-28.68,;48.4,-32.67,;47.25,-33.69,;45.93,-32.92,;45.72,-34.31,;43.8,-33.5,;42.4,-34.43,;42.75,-33.04,;44.44,-32.28,;44.38,-30.65,;43.8,-32.03,)| | ||
Structure |